Related Experiment Videos
Endotoxaemia in cystic fibrosis: response to antibiotics
Insights
Serum endotoxin levels can precisely monitor antibiotic treatment effectiveness in children with cystic fibrosis (CF) and pseudomonas lung infections. This method offers a clearer response indicator than clinical assessment alone.
Area of Science:
- Pediatric Pulmonology
- Infectious Diseases
- Biochemistry
Background:
- Cystic fibrosis (CF) patients are susceptible to chronic lung infections, particularly Pseudomonas aeruginosa.
- Monitoring treatment response in CF lung infections can be challenging with clinical assessments alone.
Purpose of the Study:
- To evaluate serum endotoxin levels as a marker for antibiotic treatment efficacy in pediatric CF patients with Pseudomonas aeruginosa lung infections.
Main Methods:
- A modified Limulus lysate technique was used to measure serum endotoxin concentrations.
- Measurements were taken in 6 children with CF undergoing intravenous antibiotic therapy.
Main Results:
- Serum endotoxin values decreased significantly during antibiotic treatment.
- The reduction in endotoxin levels indicated treatment response, sometimes more clearly than clinical signs.
Conclusions:
- Serum endotoxin monitoring provides a precise method to assess antibiotic treatment effectiveness in CF patients.
- This biochemical marker can complement clinical evaluation for Pseudomonas aeruginosa infections in CF.
Abstract:
In a study of 6 children with cystic fibrosis receiving intravenous antibiotics for pseudomonas lung infection, serum endotoxin values were monitored by a modification of the limulus lysate technique. The values fell with treatment, reflecting a response that was not always apparent on clinical assessment. Endotoxin concentrations may offer a more precise way of monitoring the effects of antibiotic treatment in CF patients.